Market closedNon-fractional
GoodRx/GDRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About GoodRx
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Ticker
GDRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Technology
Headquarters
Santa Monica, United States
Employees
694
Website
www.goodrx.com
GoodRx Metrics
BasicAdvanced
$3.3B
Market cap
-
P/E ratio
-$0.02
EPS
1.40
Beta
-
Dividend rate
Price and volume
Market cap
$3.3B
Beta
1.4
Financial strength
Current ratio
6.289
Quick ratio
5.819
Long term debt to equity
110.609
Total debt to equity
112.536
Interest coverage (TTM)
0.99%
Management effectiveness
Return on assets (TTM)
2.41%
Return on equity (TTM)
-0.90%
Valuation
Price to revenue (TTM)
4.629
Price to book
5.2
Price to tangible book (TTM)
56.34
Price to free cash flow (TTM)
40.895
Growth
Revenue change (TTM)
2.27%
Earnings per share change (TTM)
-86.29%
3-year revenue growth (CAGR)
9.77%
3-year earnings per share growth (CAGR)
-74.42%
What the Analysts think about GoodRx
Analyst Ratings
Majority rating from 20 analysts.
GoodRx Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$198M
0.61%
Net income
-$1M
-96.12%
Profit margin
-0.50%
-96.19%
GoodRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.07
$0.06
$0.08
$0.08
-
Expected
$0.06
$0.06
$0.07
$0.08
$0.09
Surprise
15.77%
3.81%
18.52%
6.57%
-
GoodRx News
AllArticlesVideos
Boehringer-GoodRx partner to offer Humira rival at 92% discount
Reuters·1 week ago
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®
PRNewsWire·1 week ago
Drug prices have risen almost 40% over the last decade, according to a new tracker
CNBC·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GoodRx stock?
GoodRx (GDRX) has a market cap of $3.3B as of July 26, 2024.
What is the P/E ratio for GoodRx stock?
The price to earnings (P/E) ratio for GoodRx (GDRX) stock is 0 as of July 26, 2024.
Does GoodRx stock pay dividends?
No, GoodRx (GDRX) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next GoodRx dividend payment date?
GoodRx (GDRX) stock does not pay dividends to its shareholders.
What is the beta indicator for GoodRx?
GoodRx (GDRX) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell GoodRx stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.